| Condition | Key Finding | Association | Board Exam Tip |
| Cushing's Syndrome | Central obesity, striae, hypochylemia | Glucocorticoid excess (mineralocorticoid effect) | Skin hyperpigmentation is not specific; it only indicates high ACTH. |
| Addison's Disease | Hypotension, Hyponatremia, Hyperkalemia, Metabolic Acidosis | Autoimmune destruction of adrenal cortex (21-hydroxylase antibodies) | Always think of the "classic triad" (low cortisol/aldosterone effects). |
| Cosyntropin Stimulation Test | Failure of serum cortisol to rise | Primary Adrenal Insufficiency | This is the definitive diagnostic test for primary AI. |
| Metyrapone | Inhibits 11β-hydroxylase | Used in Cushing's workup (alternative to ketoconazole). | Blocks late-stage cortisol synthesis, helping confirm hypercortisolism. |
| Adrenoleukodystrophy | X-linked recessive, demyelination, adrenal insufficiency | Peroxisomal disorder; impaired very long-chain fatty acid beta-oxidation | Think of a lipid/myelin/adrenal triad in boys. |
| Topic | Key Point | Context | Exam Relevance |
| Hypercortisolism | High cortisol, low ACTH (Adrenal adenoma) | Primary adrenal source; autonomous production | Requires abdominal imaging (CT/MRI) to find the tumor. |
| Cushing's Disease | High cortisol, high ACTH (Pituitary adenoma) | Secondary pituitary source; excess trophic hormone | Differentiating from ectopic sources requires HDDST and brain MRI. |
| Primary AI | Low aldosterone effect -> Hyperkalemia/Type 4 RTA | Adrenal gland failure (e.g., Addison's); loss of mineralocorticoid activity | Requires replacement of both glucocorticoids AND mineralocorticoids (Fludrocortisone). |
| Secondary AI | Aldosterone function is preserved | Pituitary/Hypothalamic failure; cortisol deficiency only | Electrolyte abnormalities are typically minimal compared to primary AI. |
| Adrenal Crisis Management | Stress dose steroids required | Critical illness, trauma, surgery; HPA axis atrophy | Never assume the patient can produce cortisol during stress. |
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A patient presents with fatigue, weight gain, central obesity, striae, and hypertension. Labs show hypochylemia and elevated 24h urinary cortisol. | Cushing's Syndrome (Hypercortisolism) | The constellation of signs points to chronic excess glucocorticoid action; the lab workup confirms hypercortisolism. |
| A patient with suspected adrenal insufficiency is found to be hypotensive, hyponatremic, and hyperkalemic. ACTH levels are markedly elevated. | Primary Adrenal Insufficiency (Addison's) | High ACTH indicates the pituitary is trying to stimulate a failing gland; low cortisol/aldosterone leads to hypotension, Na loss, and K retention. |
| A patient with Cushing's syndrome has an adrenal adenoma causing autonomous cortisol secretion. The initial workup shows high cortisol but suppressed ACTH. | Primary Adrenal Hypercortisolism (Adrenal Adenoma) | High cortisol + low ACTH suggests the problem originates in the adrenal gland, suppressing pituitary feedback. Imaging is required next. |
| A patient with suspected Cushing's syndrome has a pituitary adenoma secreting excess ACTH. The initial workup shows high cortisol and elevated ACTH. | Secondary Adrenal Hypercortisolism (Cushing's Disease) | High cortisol + high ACTH suggests the problem originates in the pituitary gland, stimulating the adrenal cortex. |
| A patient with Addison's disease is admitted to the ICU following trauma and requires IV hydrocortisone replacement due to acute stress. | Acute Adrenal Crisis | Stress demands significantly increase cortisol needs; failure to produce adequate cortisol during critical illness leads to life-threatening shock. |
| A young male presents with progressive motor deficits, demyelination on MRI, and a history of lipid abnormalities. | Adrenoleukodystrophy (X-linked) | This peroxisomal disorder impairs very long-chain fatty acid beta-oxidation, affecting both myelin sheath formation and adrenal steroid synthesis precursors. |
| Key Features | Distinguishing Findings | Next Step |
| Exogenous Steroids | High cortisol, suppressed ACTH | History of chronic steroid use; monitor for Cushingoid features. |
| Adrenal Adenoma (Primary) | High cortisol, low ACTH | Abdominal CT/MRI to localize the adrenal tumor. |
| Cushing's Disease (Secondary) | High cortisol, high ACTH | HDDST: Cortisol suppresses after high-dose dexamethasone. Brain MRI. |
| Ectopic Source | High cortisol, variable ACTH; no suppression on HDDST | Chest/Abdominal CT/MRI to find the source (e.g., SCLC). |
🚨Skin Hyperpigmentation Source: It is due to high levels of ACTH stimulating melanocytes via the precursor molecule POMC (Proopiomelanocortin), which releases MSH. This occurs in any condition causing high ACTH (e.g., primary AI, ectopic ACTH).
| Condition | Association | Mechanism | Clinical Significance |
| Addison's Disease | Autoimmune Polyglandular Syndrome Type II (APS II) | AIRE gene mutation failure to present endocrine antigens in the thymus. | High suspicion for co-existing autoimmune diseases (e.g., T1 DM, Hashimoto's). |
| Cushing's Syndrome | Glucocorticoid excess -> Mineralocorticoid effect | Cortisol binds mineralocorticoid receptors (MR) in the collecting duct. | Leads to sodium retention, potassium wasting, hypochylemia, and metabolic alkalosis. |
| Adrenoleukodystrophy | Peroxisomal disorder; X-linked recessive inheritance | Impaired beta-oxidation of very long-chain fatty acids (VLCF As). | Affects myelin formation and adrenal steroid synthesis precursors, leading to a multi-system failure. |
| Hypocortisolism | High ADH secretion -> SIADH | Cortisol deficiency impairs the maintenance of total peripheral resistance; low cortisol leads to hypotension. | The resulting SIADH causes hyponatremia. |
| Term | Definition | Context | Example |
| POMC | Proopiomelanocortin | Precursor hormone cleaved into ACTH and MSH. | High ACTH levels (e.g., primary AI) lead to high POMC cleavage, causing skin hyperpigmentation via MSH. |
| Cosyntropin | Synthetic analog of ACTH | Used in diagnostic stimulation testing for adrenal insufficiency. | If cortisol fails to rise after cosyntropin injection, it suggests primary adrenal failure. |
| Fludrocortisone | Synthetic mineralocorticoid | Replacement therapy for aldosterone deficiency (mineralocorticoid replacement). | Given alongside glucocorticoids in primary AI to maintain volume and K+. |
| AIRE Gene | Autoimmune Regulator gene mutation | Failure of central immune tolerance, leading to autoimmune destruction of endocrine glands. | Associated with APS II; seen in Addison's disease patients. |
| Metyrapone | Inhibitor of 11β-hydroxylase | Used in Cushing's workup. | Blocks the final step of cortisol synthesis, helping confirm hypercortisolism. |
| Topic | Study Approach | Priority | Resources |
| Adrenal Insufficiency | Master the primary vs secondary/tertiary distinction and associated labs (K+, Na+, Glucose). | High | Review flowcharts for cosyntropin testing; memorize electrolyte patterns. |
| Cushing's Workup | Understand the diagnostic sequence: Document -> Measure ACTH -> Test Suppression. | Medium-High | Practice interpreting LDDST and HDDST results in different clinical scenarios. |
| Autoimmune Endocrine Syndromes | Group related diseases (APS II triad) and understand the underlying genetic/immunological mechanism (AIRE). | High | Link Addison's to T1 DM and Hashimoto's; remember AIRE mutation. |